Employing nanotechnology to reduce cancer metastasis

Michael King is Professor of Biomedical Engineering at Cornell. The King lab is currently testing novel cancer therapies in mouse models of metastatic breast and prostate cancer through the use of whole body luminescence imaging. This work will uncover new therapeutic targets designed to prevent metastasis.

Report Infringement

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Working conditions and novice special educators

Next Article

Variation within households in consent

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×